Top compounds associated with response to LYZL6

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	dabrafenib	GDSC1000	pan-cancer	AAC	0.0073	0.8
mRNA	navitoclax:pluripotin (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.0088	0.8
mRNA	968	CTRPv2	pan-cancer	AAC	-0.018	0.8
mRNA	BRD-K03911514	CTRPv2	pan-cancer	AAC	0.012	0.8
mRNA	GSK1120212	CTRPv2	pan-cancer	AAC	-0.012	0.8
mRNA	BRD-K02251932	CTRPv2	pan-cancer	AAC	-0.0092	0.8
mRNA	VU0155056	CTRPv2	pan-cancer	AAC	-0.0087	0.8
mRNA	ML083	CTRPv2	pan-cancer	AAC	0.009	0.8
mRNA	navitoclax:MST-312 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.0084	0.8
mRNA	ibrutinib	CTRPv2	pan-cancer	AAC	0.0093	0.8

Download CSV